Evidence map›Paper›PMID 25182848›Full record

ArticleeLife2014

Mechanistic insight into the conserved allosteric regulation of periplasmic proteolysis by the signaling molecule cyclic-di-GMP.

Debashree Chatterjee, Richard B Cooley, Chelsea D Boyd, Ryan A Mehl, George A O'Toole, Holger Sondermann

Open access · goldAbstract read
In one paragraph

Article in eLife, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 55 citations in OpenAlex.

  1. bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. ComFB, a widespread family of c-di-NMP receptor proteins.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Review
  6. ComFB, a new widespread family of c-di-NMP receptor proteins.bioRxiv : the preprint server for biology · 2024
    Article
  7. Review
  8. Article
  9. Reconstitution of a biofilm adhesin system from a sulfate-reducing bacterium inProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Controlling Biofilm Development Through Cyclic di-GMP Signaling.Advances in experimental medicine and biology · 2022
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Debashree ChatterjeeDepartment of Molecular Medicine, College of Veterinary Medicine, Cornell University, Ithaca, United States.
Richard B CooleyDepartment of Molecular Medicine, College of Veterinary Medicine, Cornell University, Ithaca, United States.
Chelsea D BoydDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, United States.
Ryan A MehlDepartment of Biochemistry and Biophysics, Oregon State University, Corvallis, United States.
George A O'TooleDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, United States georgeo@dartmouth.edu.
Holger SondermannDepartment of Molecular Medicine, College of Veterinary Medicine, Cornell University, Ithaca, United States hs293@cornell.edu.
Cornell University · USDartmouth College · USOregon State University · US

Funding

Overall (pp. 40-62)P41GM103485 · NIGMS · CORNELL UNIVERSITY · PI CERIONE, RICHARD A. · 2012 to 2018
$15.5M
Molecular and Cellular Biology at DartmouthT32GM008704 · NIGMS · DARTMOUTH COLLEGE · PI COMPTON, DUANE A. · 1998 to 2018
$6.8M
Molecular mechanism regulating periplasmic proteolysis in bacterial pathogenesisR01AI097307 · NIAID · CORNELL UNIVERSITY · PI O'TOOLE, GEORGE A., SONDERMANN, HOLGER · 2012 to 2016
$1.9M
Mechanism and function of a conserved bacterial cyclic-di-GMP receptor systemF32GM108440 · NIGMS · CORNELL UNIVERSITY · PI COOLEY, RICHARD B · 2013 to 2014
$102k
NIAID NIH HHS R01 AI097307NIAID NIH HHS R01-AI097307NIGMS NIH HHS F32 GM108440NIGMS NIH HHS F32-GM108440NIGMS NIH HHS GM-103485NIGMS NIH HHS P41 GM103485NIGMS NIH HHS T32 GM008704NIGMS NIH HHS T32-GM08704
6 · The paper itself

Abstract

Stable surface adhesion of cells is one of the early pivotal steps in bacterial biofilm formation, a prevalent adaptation strategy in response to changing environments. In Pseudomonas fluorescens, this process is regulated by the Lap system and the second messenger cyclic-di-GMP. High cytoplasmic levels of cyclic-di-GMP activate the transmembrane receptor LapD that in turn recruits the periplasmic protease LapG, preventing it from cleaving a cell surface-bound adhesin, thereby promoting cell adhesion. In this study, we elucidate the molecular basis of LapG regulation by LapD and reveal a remarkably sensitive switching mechanism that is controlled by LapD's HAMP domain. LapD appears to act as a coincidence detector, whereby a weak interaction of LapG with LapD transmits a transient outside-in signal that is reinforced only when cyclic-di-GMP levels increase. Given the conservation of key elements of this receptor system in many bacterial species, the results are broadly relevant for cyclic-di-GMP- and HAMP domain-regulated transmembrane signaling.

Indexed as

Allosteric RegulationBacterial ProteinsBiofilmsCrystallography, X-RayCyclic GMPElectrophoresis, Polyacrylamide GelModels, MolecularMutationPeptide HydrolasesPeriplasmPeriplasmic ProteinsProtein BindingProtein Structure, TertiaryProteolysisPseudomonas fluorescensSignal TransductionBacterial Proteinsbis(3',5')-cyclic diguanylic acidCyclic GMPPeptide HydrolasesPeriplasmic Proteinsbacterial pathogensbiofilm formationc-di-GMPcell adhesionsignalingtransmembrane protein

Identifiers

PMID25182848
PMCPMC4359373
OpenAlexW2082220748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.